MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.330
0.000
0.00%
After Hours: 1.350 +0.02 +1.50% 19:53 02/06 EST
OPEN
1.360
PREV CLOSE
1.330
HIGH
1.390
LOW
1.320
VOLUME
3.75M
TURNOVER
--
52 WEEK HIGH
1.960
52 WEEK LOW
0.5150
MARKET CAP
435.34M
P/E (TTM)
-6.1347
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCGN last week (0126-0130)?
Weekly Report · 5d ago
Ocugen Inc. Stock Falls 4.6%, Underperforms Market
Dow Jones · 01/30 21:35
Ocugen Inc. Stock Slips 4.2%, Underperforms Market
Dow Jones · 01/26 21:34
Weekly Report: what happened at OCGN last week (0119-0123)?
Weekly Report · 01/26 09:38
Ocugen strengthens balance sheet with new equity financing
TipRanks · 01/23 13:26
OCUGEN, INC. ANNOUNCES CLOSING OF $22.5 MILLION UNDERWRITTEN REGISTERED DIRECT OFFERING OF COMMON STOCK
Reuters · 01/23 13:00
Ocugen: Promising OCU410 Phase 2 Efficacy, Strengthened Balance Sheet, and Large GA Market Opportunity Support Buy Rating
TipRanks · 01/23 03:56
Ocugen Inc. Stock Advances 10.7%, Outperforms Market
Dow Jones · 01/22 21:32
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.